Morphological changes in the sclera after implantation of a new intrascleral implant in an ex vivo experiment
https://doi.org/10.53432/2078-4104-2026-25-2-3-9
Abstract
PURPOSE. To evaluate the morphological features of implantation of a new intrascleral implant (ISI) made of polymethyl methacrylate in an ex vivo experiment.
METHODS. The ex vivo experiment was conducted on scleral fragments obtained from the equatorial region of the eyes of cadaveric donors aged 40–60 years. The study group included eight scleral fragments in which the ISI was implanted during simulated glaucoma surgery (GS), while the control group consisted of eight scleral fragments subjected to GS without implantation. Organotypic cultivation was performed in a standard medium under normothermic conditions for 6 months. At 14, 30, 90, and 180 days, two fragments from each group were removed from the culture for scanning electron microscopy and immunohistochemical analysis.
RESULTS. Morphological findings demonstrated that the presence of the investigated ISI in cadaveric sclera did not induce an active proliferative cellular response throughout the entire observation period (up to 6 months).
CONCLUSION. The developed polymethyl methacrylate ISI shows promise for further clinical trials in glaucoma surgery.
About the Authors
K. I. SlastinaRussian Federation
ophthalmologist, postgraduate student
59A Beskudnikovsky Blvd., Moscow, 127486
G. V. Sorokoletov
Russian Federation
Dr. Sci. (Med.), Head of the Department of Glaucoma Surgery
59A Beskudnikovsky Blvd., Moscow, 127486
S. A. Borzenok
Russian Federation
Dr. Sci. (Med.), Head of the Center for Fundamental and Applied Biomedical Problems
59A Beskudnikovsky Blvd., Moscow, 127486
D. S. Ostrovskiy
Russian Federation
Cand. Sci. (Biol.), Head of the Laboratory of Transplantology and Cell Biology of the Center for Fundamental and Applied Biomedical Problems
59A Beskudnikovsky Blvd., Moscow, 127486
M. Kh. Khubetsova
Russian Federation
Cand. Sci. (Med.), Head of the Eye Tissue Bank
59A Beskudnikovsky Blvd., Moscow, 127486
References
1. Natsional’noe rukovodstvo po glaukome dlya praktikuyuschikh vrachei [National Glaucoma Guidelines for Practitioners]. 4th edition, revised and enlarged. Edited by E.A. Egorov, V.P. Erichev. Moscow: GEOTAR-Media 2019; 384.
2. George R., Panda S., Vijaya L. Blindness in glaucoma: primary openangle glaucoma versus primary angle-closure glaucoma-a meta-analysis. Eye (Lond) 2022; 36(11):2099-2105. https://doi.org/10.1038/s41433-021-01802-9.
3. Allison K. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 2020; 12(11): e11686. https://doi.org/10.7759/cureus.11686.
4. Drouyer E., Dkhissi-Benyahya O., Chiquet C. et al. Glaucoma alters the circadian timing system. PLoS ONE 2008; 3(12):e3931. https://doi.org/10.1371/journal.pone.0003931
5. Yusef Y., Antonov A. A., Subbot A. M., et al. The problem of excessive scarring in glaucoma surgery. Part 2: Anti-inflammatory therapy, antimetabolites, angiogenesis inhibitors. National Journal of Glaucoma 2025; 24(3):66-75. https://doi.org/10.53432/2078-4104-2025-24-3-66-75
6. Lusthaus J., Goldberg I. Current management of glaucoma. Med J Aust 2019; 210(4):180-187. https://doi.org/10.5694/mja2.50020.
7. Khodjaev N.S., Kolomeitsev M.N. Experimental study of drainage properties of fibrillar structured materials for antiglaucoma surgeries. Russian Ophthalmological Journal 2018; 11(4):55-63. https://doi.org/10.21516/2072-0076-2018-11-4-55-63
8. Buratto L, Caretti, L. Glaucoma Surgery Treatment and Techniques. Switzerland, 2018, Springer International Publishing AG. 128 p.
9. Chuprov A.D., Saneeva Zh.Kh., Lanovskaya Yu.I. Experience with the use of Glautex drainage in non-penetrating deep sclerectomy. Practical Medicine 2018; 3:197-199.
10. Loskutov I.A., Andryukhina O.M., Khaldeev S.S. Glaucoma drainage surgery (literature review). Effective Pharmacotherapy 2022; 18(20): 20-26. https://doi.org/10.33978/2307-3586-2022-18-20-20-26
11. Baxant AD, Klimešová YM, Holubová L, Pluhovský P. et al. Efficacy and Safety of Deep Sclerectomy With the Esnoper Clip Implant for Uncontrolled Primary Open Angle Glaucoma: A 1 Year Prospective Study. J Glaucoma 2023; 32(3):227-235. https://doi.org/10.1097/IJG.0000000000002137
12. Germanova V.N., Karlova E.V., Korigodskiy A.R. Method of saturation of bioresorbable drainage with cyclosporine A in the prevention of postoperative scarring in glaucoma surgery. Medical and pharmaceutical journal "Pulse" 2018; 20(1):29-33.
13. Zakhidov A.B., Seleznev A.V., Gazizova I.R., Kuroedov A.V., Petrov S.Yu., Karimov U. R. Intraoperative use of antimetabolites in glaucoma surgery. National journal glaucoma 2020; 19(1):40-45. https://doi.org/10.25700/NJG.2020.01.06
Review
For citations:
Slastina K.I., Sorokoletov G.V., Borzenok S.A., Ostrovskiy D.S., Khubetsova M.Kh. Morphological changes in the sclera after implantation of a new intrascleral implant in an ex vivo experiment. National Journal glaucoma. 2026;25(2):3-9. (In Russ.) https://doi.org/10.53432/2078-4104-2026-25-2-3-9
JATS XML

















